Implantable cardioverter defibrillator: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz No edit summary |
imported>Robert Badgett No edit summary |
||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
In [[medicine]] and [[cardiology]], | In [[medicine]] and [[cardiology]], '''implantable cardioverter defibrillators''' ('''ICD'''), also called automatic '''implantable cardioverter defibrillators''' ('''AICD''') are "implantable devices which continuously monitor the electrical activity of the heart and automatically detect and terminate [[ventricular tachycardia]] and [[ventricular fibrillation]]. They consist of an impulse generator, batteries, and electrodes."<ref>{{MeSH}}</ref> | ||
==Effectiveness== | |||
Implantable cardioverter-defibrillators can reduce mortality in patients who have [[heart failure]] with an [[ejection fraction]] of less than 35%.<ref name="pmid15659722">{{cite journal |author=Bardy GH, Lee KL, Mark DB, ''et al'' |title=Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure |journal=N. Engl. J. Med. |volume=352 |issue=3 |pages=225–37 |year=2005 |pmid=15659722 |doi=10.1056/NEJMoa043399}}</ref> | Implantable cardioverter-defibrillators can reduce mortality in patients who have [[heart failure]] with an [[ejection fraction]] of less than 35%.<ref name="pmid15659722">{{cite journal |author=Bardy GH, Lee KL, Mark DB, ''et al'' |title=Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure |journal=N. Engl. J. Med. |volume=352 |issue=3 |pages=225–37 |year=2005 |pmid=15659722 |doi=10.1056/NEJMoa043399}}</ref> | ||
==Complications== | |||
AIDs may cause venous thrombosis and stenosis.<ref name="pmid15976973">{{cite journal |author=Rozmus G, Daubert JP, Huang DT, Rosero S, Hall B, Francis C |title=Venous thrombosis and stenosis after implantation of pacemakers and defibrillators |journal=J Interv Card Electrophysiol |volume=13 |issue=1 |pages=9–19 |year=2005 |month=June |pmid=15976973 |doi=10.1007/s10840-005-1140-1 |url=http://dx.doi.org/10.1007/s10840-005-1140-1 |issn=}}</ref> | |||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 15:02, 15 February 2009
In medicine and cardiology, implantable cardioverter defibrillators (ICD), also called automatic implantable cardioverter defibrillators (AICD) are "implantable devices which continuously monitor the electrical activity of the heart and automatically detect and terminate ventricular tachycardia and ventricular fibrillation. They consist of an impulse generator, batteries, and electrodes."[1]
Effectiveness
Implantable cardioverter-defibrillators can reduce mortality in patients who have heart failure with an ejection fraction of less than 35%.[2]
Complications
AIDs may cause venous thrombosis and stenosis.[3]
References
- ↑ Anonymous (2024), Implantable cardioverter defibrillator (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Bardy GH, Lee KL, Mark DB, et al (2005). "Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure". N. Engl. J. Med. 352 (3): 225–37. DOI:10.1056/NEJMoa043399. PMID 15659722. Research Blogging.
- ↑ Rozmus G, Daubert JP, Huang DT, Rosero S, Hall B, Francis C (June 2005). "Venous thrombosis and stenosis after implantation of pacemakers and defibrillators". J Interv Card Electrophysiol 13 (1): 9–19. DOI:10.1007/s10840-005-1140-1. PMID 15976973. Research Blogging.